Wikidata

(Q61922929)

English

Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)

clinical trial

In more languages
default for all languages
No label defined

No description defined

Statements

title
Cetrorelix Pamoate Intermittent Intramuscular (IM) Dosage Regimens in Patients With Symptomatic BPH: a 1 Year Placebo-controlled Efficacy Study and Long-term Safety Assessment (English)
0 references
sponsor
Aeterna Zentaris
0 references
country
Bulgaria
0 references
Canada
0 references
Germany
0 references
start time
March 2007
0 references
end time
June 2009
0 references
number of participants
667
0 references
minimum age
50 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q61922929&oldid=2173844293"